PROTOONCOGENE EXPRESSION IN DIFFERENTIATING AND NONDIFFERENTIATING CHRONIC MYELOGENOUS LEUKEMIA-CELLS

被引:6
|
作者
WANG, Z
YIN, MY
XIE, XX
YANG, PM
SATO, H
MAYERS, G
RIOBOWAL, C
PREISLER, HD
机构
[1] BARRETT CTR CANC PREVENT TREATMENT & RES,234 GOODMAN ST,CINCINNATI,OH 45267
[2] UNIV CINCINNATI,MED CTR,CINCINNATI,OH 45267
[3] KANTO TEISHIN HOSP,SHINAGAWA KU,TOKYO 141,JAPAN
[4] PK MEM INST,BUFFALO,NY
关键词
D O I
10.1016/0277-5379(90)90119-E
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite the profound differences between the chronic and blastic phases of chronic myelogenous leukaemia, no differences between chronic and blastic phase cells have been described at the molecular level. Differences have been found in the levels of expression of c-myc, c-myb and p53, which fell when chronic phase cells were cultured, while the levels of expression of the genes were stable when blastic crisis cells were cultured. In contrast c-fms expression increased and MRS expression decreased after culture of chronic or blastic phase cells. The data suggest that the regulation of expression of some genes in blastic crisis cells is unaltered while that of others is disrupted. It is not known whether the failure of c-myc, c-myb and p53 expression to fall during the culture of blastic phase cells is the cause of or a reflection of the failure of these cells to differentiate. © 1990.
引用
收藏
页码:694 / 698
页数:5
相关论文
共 50 条
  • [31] PLASMINOGEN-ACTIVATOR ACTIVITY IN DIFFERENTIATING LEUKEMIA-CELLS
    KIDRON, M
    NACHSHON, I
    MAYER, M
    FIBACH, E
    FEBS LETTERS, 1984, 177 (01): : 66 - 70
  • [32] DIFFERENTIATION OF HUMAN ACUTE MYELOGENOUS LEUKEMIA-CELLS - THERAPEUTIC POSSIBILITIES
    TOBLER, A
    KOEFFLER, HP
    ACTA HAEMATOLOGICA, 1987, 78 : 127 - 135
  • [33] CRKL LINKS P210(BCR/ABL) WITH PAXILLIN IN CHRONIC MYELOGENOUS LEUKEMIA-CELLS
    SALGIA, R
    UEMURA, N
    OKUDA, K
    LI, JL
    PISICK, E
    SATTLER, M
    DEJONG, R
    DRUKER, B
    HEISTERKAMP, N
    CHEN, LB
    GROFFEN, J
    GRIFFIN, JD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (49) : 29145 - 29150
  • [34] MONOCLONAL-ANTIBODIES REACTIVE WITH ACUTE MYELOGENOUS LEUKEMIA-CELLS
    LINKERISRAELI, M
    BILLING, RJ
    FOON, KA
    TERASAKI, PI
    JOURNAL OF IMMUNOLOGY, 1981, 127 (06) : 2473 - 2477
  • [35] MAINTENANCE OF REMISSION IN ACUTE MYELOGENOUS LEUKEMIA BY A MIXTURE OF BCG AND IRRADIATED LEUKEMIA-CELLS
    POWLES, RL
    SELBY, PJ
    JONES, DR
    RUSSELL, JA
    PRENTICE, HG
    MCELWAIN, TJ
    LANCET, 1977, 2 (8048) : 1107 - 1110
  • [36] CONTROL OF GLOBIN GENE-EXPRESSION BY STEROID-HORMONES IN DIFFERENTIATING FRIEND LEUKEMIA-CELLS
    LO, SC
    AFT, R
    ROSS, J
    MUELLER, GC
    CELL, 1978, 15 (02) : 447 - 453
  • [37] GENETIC-REGULATION OF THE EXPRESSION OF THE TRANSFERRIN RECEPTOR IN DIFFERENTIATING HL-60 LEUKEMIA-CELLS
    HO, PTC
    SARTORELLI, AC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 12 - 12
  • [38] STORAGE CELLS OF CHRONIC MYELOGENOUS LEUKEMIA
    LEE, RE
    ELLIS, LD
    LABORATORY INVESTIGATION, 1971, 24 (04) : 261 - &
  • [39] IDENTIFICATION OF CRKL AS THE CONSTITUTIVELY PHOSPHORYLATED 39-KD TYROSINE PHOSPHOPROTEIN IN CHRONIC MYELOGENOUS LEUKEMIA-CELLS
    NICHOLS, GL
    RAINES, MA
    VERA, JC
    LACOMIS, L
    TEMPST, P
    GOLDE, DW
    BLOOD, 1994, 84 (09) : 2912 - 2918
  • [40] IMMUNOLOGICAL HETEROGENEITY OF THE FOLATE-BINDING PROTEINS FROM CHRONIC MYELOGENOUS LEUKEMIA-CELLS AND MYELOFIBROSIS SPLEEN
    DACOSTA, M
    FISHER, C
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1981, 98 (06): : 956 - 964